alexa Adherence To IEC62366 May Not Ensure A Successful FDA Review: A Case Study
ISSN: 2167-7689

Pharmaceutical Regulatory Affairs: Open Access
Open Access

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

3rd International Conference on Pharmaceutical Regulatory Affairs
October 21-23, 2013 DoubleTree by Hilton Hotel San Francisco Airport, CA, USA

Dean Hooper
Accepted Abstracts: Pharmaceut Reg Affairs
DOI: 10.4172/2167-7689.S1.012
Abstract
Compliance to ISO/IEC 62366 ensures the medical device manufacturer has performed due diligence in the design and development of the product so as to minimize the risk of harmful use error. This standard also lays out a user centered design process that should enhance the product?s general usability once market released. It has expanded the scope of its preceding standard, which was solely for electrical medical devices (ISO/IEC 60601-1-6: Medical electrical equipment - part 1-6: General requirements for safety - Collateral standard: Usability), to include all medical devices. The 62366 standard is often used when applying for a product?s CE Mark. In essence, the device manufacturer may choose to show that activities have been performed for the specific product of interest or demonstrate that their overall product development process adheres to 62366. And it has become common for manufacturers to submit such compliance to the FDA for US release; especially for those attempting to enter the US market after CE mark. However, for a successful market release in the US, adherence to IEC62366 may be necessary but definitely not sufficient for a successful FDA review. In fact, the FDA has pointedly responded to the industry due to new product and 510 k submissions that tout such compliance as evidence use error has been investigated. They explicitly state they will not accept compliance alone as evidence that the design of the product would minimize the occurrence of use error. Through a case study, this presentation will detail the common FDA review comments concerning IEC62366 compliance. Details will be presented on how these discrepancies were successfully addressed and, ultimately, how to avoid initial obstacles all together by outlining the FDA human factors review guidelines currently in effect.
Biography
Dean Hooper is Principal at HE Consulting. He provides user-centered design expertise to all phases of product development, from initial needs gathering to final product validation. His strength lies in being proficient at simultaneously providing human factors input for optimal product design while contributing to successful regulatory submissions. He has provided human factors input to software and hardware development projects for over 18 years; the past 13 applying and directing user-centered activities to deliver safe and easy to use medical devices and associated peripherals; from Cardiac Rhythm management to robotic surgical systems. He has been awarded design patents and produced several publications; most recently on the evaluation of medical device use error and building user-centered programs to meet regulatory pressure to demonstrate safe design before market release. He received an M.S in Cognitive Science from New Mexico State University where he studied cognitive processes involved in word and speech recognition.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords